An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (19)
  • Podcast (13)
  • Publications (652)
  • Training (6)
  • User case (13)
  • User meeting (21)
  • Webinar (119)
  • White paper (8)
Key content topics
Key audience
  • Newcomers (6)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)

The first prototype of spot-scanning proton arc treatment delivery.

03/05/2019
/ Publications
/
ARC therapy
IMPT

Published in the Green Journal, the Beaumont group reported the first prototype of spot-scanning arc treatment (SPArc) delivery on IBA Proteus®One. The brain...

Comparison between patient-reported outcomes after enucleation and proton beam radiotherapy for uveal melanomas: a 2-year cohort study.

03/04/2019
/ Publications

This study compared differential effects of enucleation and PBR on 115 uveal melanoma patients based on the patient-reported outcomes. This study found that PBR...

Are further studies needed to justify the use of proton therapy for paediatric cancers of the central nervous system?

03/01/2019
/ Publications

A review article published in the Green Journal. Having analyzed the available data of PBT for paediatric cancers of the central nervous system (CNS), this...

Prospective, Longitudinal Comparison of Neurocognitive Change in Pediatric Brain Tumor Patients Treated with Proton Radiotherapy versus Surgery Only.

03/06/2019
/ Publications

93 patients (22 proton CSI, 31 proton focal, and 40 surgery only) received annual neurocognitive evaluations for up to 6 years, including Full Scale IQ (FSIQ)...

Improved neuropsychological outcomes following proton therapy relative to x-ray therapy for pediatric brain tumor patients.

03/03/2019
/ Publications

This study analyzed 125 children who received radiation (XRT or PRT) and had post-treatment neuropsychological evaluation including intelligence (IQ), attention...

Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma (RMS).

03/02/2019
/ Publications
/
Chemotherapy

A MD Anderson study published in the Green Journal reported on the patterns of failure following proton beam therapy (PBT) for pediatric H&N RMS. 46 patients...

Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry.

03/01/2019
/ Publications

A paper by MGH published in the Green Journal evaluated the factors that affect maximum follow-up time among MGH Pediatric Proton Consortium Registry (PPCR)...

Efficacy of PT in children with high-risk and locally recurrent neuroblastoma.

03/05/2019
/ Publications

Eighteen patients with high-risk (n = 16) and locally recurrent neuroblastoma (n = 2) were treated with proton therapy. With a median follow-up of 60.2 months...

A prospective clinical trial of PT for chordoma and chondrosarcoma

03/05/2019
/ Publications

This study evaluated outcome of PBT for chordomas and chondrosarcomas. 20 adult patients with nonmetastatic chordomas of the skull base (n = 10), sacrum (n = 5)...

Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer.

03/04/2019
/ Publications
/
Chemotherapy

A study by the Tsukuba group in Japan repored outcomes of 42 unresectable locally advanced pancreatic cancer patients treated with PBT and concurrent...

Pagination

  • Previous page ‹
    • Page 26
    • Current page 27
    • Page 28
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies